Discount Vitamins & Herbs

   
- Products by Category
- Alphabetic Product Listing

Home Go Shopping Specials Product Info Health News FAQs About Us Links Site Map

Hyaluronic Acid Center, Neptune Krill Oil & Rejuvenation Science for Doctors

Friday, September 28, 2007

Case Report: Parenteral Magnesium for End-Stage Cardiomyopathy

A 57-year-old man came to see me from several hundred miles away with a 15-year history of slowly progressive dilated cardiomyopathy. He was still functioning relatively well, although he did experience shortness of breath after moderate exertion. The patient was advised to take various nutrients that support cardiovascular function, including coenzyme Q10, magnesium, and L-carnitine, to continue seeing his cardiologist, and to check in with me periodically by phone. He was also advised to take a series of weekly intramuscular magnesium injections, but he was unable to find a practitioner in his town willing to administer them.

Within ten minutes of receiving the first intra-muscular magnesium injection, the patient converted from atrial fibrillation to normal sinus rhythm, and he appeared to be improved overall.

Read details on this magnesium for end-stage cardiomyopathy case.

Wednesday, September 26, 2007

Does Vitamin D Deficiency Lead to Heart Failure?

This review article points out that the majority of patients with congestive heart failure have vitamin D insufficiency.

Vitamin D deficiency in these patients is presumably due in part to relatively low amounts of outdoor activity. Vitamin D deficiency may contribute to the pathogenesis of heart failure, or may exacerbate heart failure, by promoting the development of hypertension.

In recent years, evidence has accumulated that vitamin D deficiency is very common and may contribute to the development of muscle weakness and pain, some autoimmune diseases, osteoporosis, infections, and cancer.

View details of this vitamin D heart failure review article.

Monday, September 24, 2007

Omega-3 EPA and DHA Improves C-Reactive Protein Level

Forty men with a history of myocardial infarction who had completed a cardiac rehabilitation program were randomly assigned to receive Omega-3 EPA & DHA and other nutritional factors or placebo.

C-reactive protein is a marker of inflammation. An elevated serum C-reactive protein level is an independent risk factor for coronary heart disease. The results of this study demonstrate that supplementation with modest doses of fatty acids, vitamin E, and B vitamins can significantly reduce C­reactive protein levels in patients with a history of myocardial infarction.

Read details on this omega-3 EPA and DHA c-reactive protein study.

Thursday, September 20, 2007

Pomegranate Extracts Inhibit Prostate Cancer Growth

Ellagitannins from pomegranate accumulate in the prostate and may be the reason for the reported pomegranate benefits, suggests a new animal study.

The study, published in the Journal of Agricultural and Food Chemistry, also reports that the growth of prostate cancer cells was significantly inhibited by the pomegranate ellagitannins and their metabolites. "We have shown that pomegranate ellagitannins metabolites are concentrated to a high degree in mouse prostate tissues," wrote the authors.

Read details of this pomegranate prostate cancer study.

Wednesday, September 19, 2007

Quercetin Reduces Upper Respiratory Tract Infections

Quercetin, a flavonoid found in fruit, such as apples and berries, helps reduce illnesses in people who have carried out extensive exercise.

Researchers writing in the Medicine and Science in Sports and Exercise journal found that supplementation of quercetin reduced incidence of upper respiratory tract infections (URTI). This study adds to an increasing body of evidence pointing to the health benefits of the antioxidant quercetin, which has been linked to having an ability to fight oxidative stress as well as anti-cancer benefits.

Read details on this quercetin upper respiratory tract infection study.

Tuesday, September 18, 2007

Low Vitamin D Linked to Preeclampsia

A study has linked low vitamin D levels in mothers to a five-fold increased risk of preeclampsia, a serious complication in pregnancy which can lead to fetal death.

Preeclampsia is marked by soaring blood pressure and swelling of the hands and feet, and is the leading cause of premature delivery and maternal and fetal illness and death worldwide, thought to contribute to 76,000 deaths each year.

Low vitamin D early in pregnancy was associated with a five-fold increase in the odds of preeclampsia. Even a small decline in vitamin D concentration more than doubled the risk of preeclampsia.

View details on this vitamin D preeclampsia study.

Monday, September 17, 2007

N-Acetyl Cysteine Supplementation Helps Gamblers Curb Addiction

N-Acetyl Cysteine, an amino acid helps diminish pathological gambling addictions, according to a new study. 60 percent of the participants reported having less urges to gamble.

Thirteen of the 16 participants who responded to the amino acid the first time around agreed to continue in the double-blind study (the other three did not want to risk quitting the drug they were on) for an additional six weeks. Of these, around 83 percent who received the supplement continued to report fewer urges to gamble and nearly 72 percent of those who took the placebo went back to gambling. N-acetyl cysteine is said to have an impact on the chemical glutamate, which is often associated with reward in the brain.

Read details about this N-Acetyl Cysteine gambling addiction study.

Sunday, September 16, 2007

CLA Causes Fat Loss

The efficacy of Conjugated Linolenic Acid (CLA) as a weight management supplement has been supported in a new animal study, which found CLA boosted weight loss.

Researchers writing in the Journal of Food Science found that mice that were fed CLA lost weight by reducing body fat. They found similar weight loss was achieved by either taking CLA or restricting how much food was eaten.

Researchers concluded, "CLA may be best used in conjunction with other dietary interventions to control obesity and related health risks."

Read more about this CLA fat loss study.

Thursday, September 13, 2007

AMA Announces Vitamin D Supplements Associated With Lower Risk of Death

In a press release, the American Medical Association (AMA) announced that individuals who take vitamin D supplements have a lower risk of death from any cause over an average follow-up time of six-years, according to a meta-analysis of 18 previously published studies.

I can't decide which is the bigger news - the AMA supporting the results of a meta-analysis of 57,000 cases indicating that vitamin supplementation is beneficial for reducting mortality, or the 7% reduction in death rate due to vitamin D supplementation.

Vitamin D refers to two biologically inactive precursors - D3, also known as cholecalciferol, and D2, also known as ergocalciferol. Vitamin D-3 is produced in the skin on exposure to UVB radiation (290 to 320 nm), and is more bioactive. Vitamin D-2 is derived from plants and only enters the body via the diet.

Read details on vitamin D supplementation mortality rate reduction.

Wednesday, September 12, 2007

Neptune Krill Oil Helps Reduce Chronic Inflammation and Arthritic Pain

Chronic inflammation is closely associated with the destruction of the arteries in atherosclerosis and of the joints in osteoarthritis and the autoimmune disease, rheumatoid arthritis.

One of the most useful markers of inflammation is the presence of C-reactive protein (CRP). It is a strong predictor of cardiac events and the level of CRP in the blood stream correlates closely with inflammation, joint destruction, and pain in both osteoarthritis and rheumatoid arthritis.

Neptune Krill Oil was examined in this study to see what effect it might have on chronic inflammation as measured by CRP. Krill oil contains large amounts of phospholipids, potent antioxidants including astaxanthin and a high ratio of omega-3 to omega-6 fatty acids.

After 14 days, the NKO group had reduced their CRP levels by 29.7% while the placebo group had increased their CRP by 32.1%. In conclusion, 300mg per day of Neptune Krill Oil appears to significantly inhibit inflammation.

View details of this Neptune Krill Oil chronic inflammation and artiritis study.

Tuesday, September 11, 2007

Neptune Krill Oil Demonstrates Positive Economic Benefit for Dyslipidemia Treatment

Neptune Technologies & Bioressources Inc. is pleased to announce significantly positive results after the completion of a population-based risk–benefit and a health-economics analysis study for Neptune Krill Oil (NKO™) in the management of dyslipidemia.

The results of the study demonstrate the following:
a. Patients treated with Neptune Krill Oil had significantly reduced risk for cardiovascular events over the next 10 years, by 52%.
b. Patients treated with NKO had a significantly higher chance (-52.3%) to prevent cardiovascular events over the next 10 years when compared to those treated with Fish Oil (-8.9%) or the statin resistant patients treated with low dose statin (83.6%).
c. NKO monotherapy as well as NKO co-administered with a low dose statin was significantly more cost-effective than all other interventions studied for all types of cardiovascular events aggregated.
d. From a cost-benefit perspective NKO remains the most favorable treatment alternative for angina, congestive heart failure, stroke, myocardial infarction, Percutaneous Transluminal Coronary Angioplasty (PTCA), fatal myocardial infarction and coronary artery bypass graft surgery (CABG); NKO has a negative cost-benefit indicating that the cost of acquisition is less than the benefits derived from the intervention.

Read details of this Neptune Krill Oil dyslipidemia economic benefit study.

Saturday, September 08, 2007

Probiotics Reduce Inflammatory Bowel Disease (IBD)

A series of probiotic studies on mice have presented positive results in protecting newborns from intestinal infections and reducing inflammatory bowel disease (IBD), research by Institut Rosell suggests.

The researchers said that overall disease activity index decreased significantly with the treatments within a week, as compared to untreated control. The study shows the efficacy of Lp299v, either alone or with Rosehip drink, in attenuating inflammation and improving the intestinal barrier function (reduced bacterial translocation in the gut), as well as its antioxidant capacity, they said.

View details of this probiotic inflammatory bowel disease study.

Friday, September 07, 2007

Vitamin D Could Reduce Breast and Colon Cancer 50%

As many as 50 percent of breast and colon cancer cases could be prevented by increasing intake of vitamin D, according to a study that backs continued calls for higher vitamin D upper limits.

According to the study's projections, in North America, a 50 percent reduction in colon cancer incidence would require universal intake of 2000 IU (International Units) per day of vitamin D, and a 50 percent reduction in breast cancer would require 3500 IU per day.

According to the study, the median adult intake of vitamin D in the US is only 230 IU per day, versus the researchers' recommended 2000 IU per day. In addition, they called into question the type of vitamin D used. "Use of ergocalciferol (vitamin D2), which is popular in Europe and is used in some major [inexpensive] US brands of multivitamins, should be discontinued immediately in favor of vitamin D3."

Read details of this vitamin D breast and colon cancer risk reduction study.

Tuesday, September 04, 2007

Resveratrol Reduces Prostate Cancer Risk 87%

Researchers at the University of Alabama at Birmingham (UAB) have found that resveratrol, found in red wine, helps reduce the risk of developing prostate cancer.

In the study, resveratrol-fed mice showed an 87 percent reduction in their risk of developing prostate tumors that contained the worst kind of cancer-staging diagnosis. The mice that proved to have the highest cancer-protection effect earned it after seven months of consuming resveratrol in a powdered formula mixed with their food.

Read more information on this resveratrol prostate cancer study.